Advanced Medical Isotope Corporation (trading symbol QB:ADMD)
1021 N. Kellogg St. Kennewick, Washington 99336 US
T: 509.736.4000 F: 509.736.4007 E: info@isotopeworld.com

Tags

Latest News

Advanced Medical Isotope CEO Releases Shareholder Letter Outlining New Streamlined Path to FDA Submission

(Tue, 14, Feb 2017) >> read more

 

Advanced Medical Isotope CEO Issues Letter to Shareholders Issues Full Status Update, Planned FDA Submission Pathway and Business Plan for 2017 and Beyond

(Wed, 11, Jan 2017) >> read more

 

Advanced Medical Isotope announced today that Dr. Michael Korenko, Ph. D., who formerly served as an advisor to the Board, was named as AMI's interim President and Chief Executive Officer, replacing James Katzaroff.

(Tue, 20, Dec 2016) >> read more

 

Advanced Medical Isotope announced today that it has been awarded in the Superior Court of the State of Washington in and for Benton County, a total judgment of $527,875.74 USD. 
(Fri, 2, Dec 2016) >> read more

 

 Click here for more news and updates

Social Media


Awards & Recognition - AMIC has been recognized as a leader by local, state and federal agencies.

 

• $1.3 million U.S. Federal grant for brachytherapy 

• Leaders in Healthcare Award, Seattle Business Magazine

• Federal Laboratory Consortium Award for Excellence in Technology Transfer, 

   a prestigious honor recognized by the US Secretary of Energy and US Senator Murray

 

2016 - World Council on Isotopes Special Report
Special Report on Advances in Medical Radiotherapy featuring Dr. Alan Walter, Chairman Scientific Advisory Board and James Katzaroff, Chairman, CEO and Founder at Advanced Medical Isotope Corporation
2016 WCI Newsletter January Edition.pdf
Adobe Acrobat Document 431.7 KB

 

2015 - AMIC awarded $250,000 Life Sciences Discovery Fund Grant as Commercialization Partner 

 

Focus: To test a novel technology for delivering high-dose radiation to solid cancers that cannot be removed surgically

Anticipated Impact: Safer, more effective treatment of radiation-resistant solid cancers

 

Principal Investigator: Dr. Darrell Fisher
Grantee Organization: Washington State University
Grant Title: Optimized Injectable Radiogels for High-dose Therapy of Non-resectable Solid Tumors
Grant Cohort and Year: 2015 Proof of Concept (03)
Grant Period: 03/01/2015 - 02/28/2017 (Active)
Grant Amount: $250,000

August 3, 2013 - The Secretary of Energy, Washington, D.C.

Secretary of Energy 2013 Award for Excellence in Technology Transfer
DOE Award of Excellence in Technology.pd
Adobe Acrobat Document 324.1 KB